Corresponding Author: Christopher A. Schutt, MD, Department of Neurotology, Michigan Ear Institute, 30055 Northwestern Hwy, #101, Farmington Hills, MI 48334 (caschutt13@gmail.com).
Published Online: July 15, 2021. doi:10.1001/jamaoto.2021.1510
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank the patient for granting permission to publish this information.
1.Sweeney
AD , Hunter
JB , Rajkumar
SV , Lane
JI , Jevremovic
D , Carlson
ML . Plasmacytoma of the temporal bone, a great imitator: report of seven cases and comprehensive review of the literature.
Otol Neurotol. 2017;38(3):400-407. doi:
10.1097/MAO.0000000000001317
PubMedGoogle ScholarCrossref 3.Tsang
RW , Campbell
BA , Goda
JS ,
et al. Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the International Lymphoma Radiation Oncology Group.
Int J Radiat Oncol Biol Phys. 2018;101(4):794-808. doi:
10.1016/j.ijrobp.2018.05.009
PubMedGoogle ScholarCrossref 4.Kilciksiz
S , Karakoyun-Celik
O , Agaoglu
FY , Haydaroglu
A . A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.
ScientificWorldJournal. 2012;2012:895765. doi:
10.1100/2012/895765
PubMedGoogle Scholar 7.Ghiassi-Nejad
Z , Ru
M , Moshier
E , Chang
S , Jagannath
S , Dharmarajan
K . Overall survival trends and clinical characteristics of plasmacytoma in the United States: a national cancer database analysis.
Clin Lymphoma Myeloma Leuk. 2019;19(5):310-319. doi:
10.1016/j.clml.2019.01.004
PubMedGoogle ScholarCrossref